Share of Cost, Common heartburn drugs tied to higher risk of death
Use of proton pump inhibitors – a class of drug taken by millions to treat heartburn and reduce stomach acid – is tied to a higher risk of premature death. So concludes a large study that followed nearly 350,000 United States veterans.
Reporting their findings in the journal BMJ Open, researchers from Washington University School of Medicine in St. Louis explain how they also found that the risk of death rose with longer use of proton pump inhibitors (PPIs).
“No matter how we sliced and diced the data from this large dataset, we saw the same thing: there’s an increased risk of death among PPI users,” says senior author Ziyad Al-Aly, an assistant professor of medicine.